These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6139123)

  • 1. Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?
    Rolf Smith S; Kendall MJ; Worthington DJ; Holder R
    Br J Clin Pharmacol; 1983 Nov; 16(5):557-60. PubMed ID: 6139123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonsteady-state agonist antagonist interaction model using plasma potassium concentrations to quantify the beta-2 selectivity of beta blockers.
    Jonkers R; van Boxtel CJ; Koopmans RP; Oosterhuis B
    J Pharmacol Exp Ther; 1989 Apr; 249(1):297-302. PubMed ID: 2565392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic influence on esophageal and colonic motility in man.
    Lyrenäs E
    Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective and non-selective beta-adrenergic agents on insulin secretion in vivo.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1981 Apr; 71(1):93-104. PubMed ID: 6113155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate production and contractile response induced by beta-adrenoceptor subtypes in rabbit urinary bladder smooth muscle.
    Morita T; Dohkita S; Kondo S; Nishimoto T; Hirano S; Tsuchida S
    Urol Int; 1990; 45(1):10-5. PubMed ID: 1968300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hypotensive effect of combined beta1-adrenoceptor blockade and beta2-adrenoceptor stimulation in spontaneously hypertensive rats (SHR).
    Malatray J; Gautier E; Lundgren B; Carlsson E; Fellenius E
    Eur J Pharmacol; 1977 Jan; 41(1):13-6. PubMed ID: 12983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection by blockade of beta 2-adrenoceptors.
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx FH; Wenting GJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():109-15. PubMed ID: 6137369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.
    William-Olsson T; Fellenius E; Björntorp P; Smith U
    Acta Med Scand; 1979; 205(3):201-6. PubMed ID: 218427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.
    Bax ND; Lennard MS; Tucker GT
    Br J Clin Pharmacol; 1981 Dec; 12(6):779-84. PubMed ID: 6122461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes.
    Wu BN; Shen KP; Lin RJ; Huang YC; Chiang LC; Lo YC; Lin CY; Chen IJ
    Gen Pharmacol; 2000 May; 34(5):321-8. PubMed ID: 11368887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of beta 2- and beta 3-adrenoceptors in plasma potassium control in conscious rabbits.
    Reverte M; García-Barrado MJ; Hernández-García FJ; Moratinos J
    J Auton Pharmacol; 1993 Jun; 13(3):227-36. PubMed ID: 8099912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor agonists and antagonists on thyroid hormone secretion.
    Ahrén B; Rerup C
    Eur J Pharmacol; 1983 Apr; 88(4):383-7. PubMed ID: 6134629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M; Akhlaghi S; Hughes B; Lewis H
    J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.